• William Himmelsbach was named president/CEO of the Cardiovascular Research Foundation (CRF; New York). Previously, Himmelsbach was senior VP at VHA and executive officer of its New York-based VHA Empire-Metro. CRF is an independent, academically focused nonprofit organization dedicated to developing innovative therapies for the millions of people around the world suffering from heart disease.

• CombiMatrix (Mukilteo, Washington) said that Karine Hovanes, PhD, has joined its wholly owned subsidiary, Combimatrix Molecular Diagnostics (CMDX), as its Laboratory Director. Dr. Hovanes is a Diplomat of the American Board of Medical Genetics in Clinical Molecular Genetics and Clinical Cytogenetics and is also licensed in New York and California in both cytogenetics and molecular genetics. Dr. Hovanes joins CMDX from Laboratory Corporation of America. CombiMatrix specializes in drug development, genetic analysis, molecular diagnostics, nanotechnology and defense products.